HK drug sector should raise GMP standards, report
The Hong Kong pharma sector should aim to adopt current World Health Organisation (WHO) GMP standards for drug manufacture within two years, according to a new report.
The Hong Kong pharma sector should aim to adopt current World Health Organisation (WHO) GMP standards for drug manufacture within two years, according to a new report.
Daiichi-Sankyo subsidiary Luitpold Pharmaceuticals has acquired PharmaForce, giving it a 40,000 sq ft cGMP compliant sterile manufacturing facility and a 20,000 sq ft API production plant.
Lab Research (LR) claims it is the first preclinical CRO laboratory to develop a cardiopulmonary monitoring telemetry system.
Pfizer will soon sell more generic pharmaceuticals in the US after its agreement with Indian non-branded drugmaker Strides Arcolab.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at DPT Laboratories, Datatrak and Dishman.
CRO Particle Sciences (PSI) is improving its formulation and characterisation abilities by acquiring a multimodal imaging system from Horiba.